Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Prete

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Journal of Endocrinological Investigation|March 3, 2026
Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinomaAntonio Matrone, Carla Gambale, Liborio Torregrossa, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2022
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to SelpercatinibRossella Elisei, Raffaele Ciampi, Antonio Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2024
Inflammation-based Scores in Patients With PheochromocytomaChiara Parazzoli, Alessandro Prete, Vittoria Favero, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2026
Calcitonin Thresholds for Prediction of Medullary Thyroid Carcinoma and its Clinical Response in MEN2A Gene CarriersAlessandro Prete, Antonio Matrone, Cristina Romei, et al.
European Journal of Endocrinology|August 17, 2023
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic studyJuliane Lippert, Ulrich Dischinger, Silke Appenzeller, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2023
Pheochromocytomas Most Commonly Present As Adrenal Incidentalomas: A Large Tertiary Center ExperienceSunil Aggarwal, Alessandro Prete, Vasileios Chortis, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2024
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active SurveillanceTeresa Ramone, Arianna Ghirri, Alessandro Prete, et al.
Case Reports in Endocrinology|December 4, 2025
Prolonged Mitotane Administration in Metastatic Adrenocortical Carcinoma With Over a Decade of Survival: A Case SeriesLorenzo Tucci, Mengjie Xu, Miriam Asia, et al.
Iscience|October 13, 2019
Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted SequencingRaffaele Ciampi, Cristina Romei, Teresa Ramone, et al.
Genes|January 1, 2021
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic FrequencyTeresa Ramone, Chiara Mulè, Raffaele Ciampi, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Journal of Endocrinological Investigation|March 3, 2026
Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinomaAntonio Matrone, Carla Gambale, Liborio Torregrossa, et al.
The Journal of Clinical Endocrinology and Metabolism|May 26, 2022
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to SelpercatinibRossella Elisei, Raffaele Ciampi, Antonio Matrone, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2024
Inflammation-based Scores in Patients With PheochromocytomaChiara Parazzoli, Alessandro Prete, Vittoria Favero, et al.
The Journal of Clinical Endocrinology and Metabolism|February 14, 2026
Calcitonin Thresholds for Prediction of Medullary Thyroid Carcinoma and its Clinical Response in MEN2A Gene CarriersAlessandro Prete, Antonio Matrone, Cristina Romei, et al.
European Journal of Endocrinology|August 17, 2023
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic studyJuliane Lippert, Ulrich Dischinger, Silke Appenzeller, et al.
The Journal of Clinical Endocrinology and Metabolism|July 7, 2023
Pheochromocytomas Most Commonly Present As Adrenal Incidentalomas: A Large Tertiary Center ExperienceSunil Aggarwal, Alessandro Prete, Vasileios Chortis, et al.
The Journal of Clinical Endocrinology and Metabolism|August 24, 2024
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active SurveillanceTeresa Ramone, Arianna Ghirri, Alessandro Prete, et al.
Case Reports in Endocrinology|December 4, 2025
Prolonged Mitotane Administration in Metastatic Adrenocortical Carcinoma With Over a Decade of Survival: A Case SeriesLorenzo Tucci, Mengjie Xu, Miriam Asia, et al.
Iscience|October 13, 2019
Genetic Landscape of Somatic Mutations in a Large Cohort of Sporadic Medullary Thyroid Carcinomas Studied by Next-Generation Targeted SequencingRaffaele Ciampi, Cristina Romei, Teresa Ramone, et al.
Genes|January 1, 2021
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic FrequencyTeresa Ramone, Chiara Mulè, Raffaele Ciampi, et al.
Pageof 11